Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abrams

Showing results (301-310 of 371) with videos related to

Pageof 38
Sort By:
Cell Death Discovery|September 29, 2021
Signaling through TLR5 mitigates lethal radiation damage by neutrophil-dependent release of MMP-9Craig M Brackett, Kellee F Greene, Alyssa R Aldrich, et al.
Annals of Internal Medicine|July 21, 2010
Contextual errors and failures in individualizing patient care: a multicenter studySaul J Weiner, Alan Schwartz, Frances Weaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2015
Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancersJulia L Marcus, Chun Chao, Wendy A Leyden, et al.
Research Square|November 24, 2025
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancerPriyanka Rajan, Robert Zollo, Yanqi Guo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 2011
HIV infection, immunodeficiency, viral replication, and the risk of cancerMichael J Silverberg, Chun Chao, Wendy A Leyden, et al.
Integrative Cancer Therapies|February 27, 2013
Integrating dietary supplements into cancer careMoshe Frenkel, Donald I Abrams, Elena J Ladas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancerPriyanka Rajan, Robert Zollo, Yanqi Guo, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2026
Iron diminishes immunosuppressive macrophages and enhances anti-PD-1 immunotherapy in breast cancer modelsQingfei Wang, Elizabeth L Adams, Rylee A Poole, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancersFengzhi Li, Xiang Ling, Sayan Chakraborty, et al.
Pageof 38

Showing results (301-310 of 371) with videos related to

Sort By:
Pageof 38
Cell Death Discovery|September 29, 2021
Signaling through TLR5 mitigates lethal radiation damage by neutrophil-dependent release of MMP-9Craig M Brackett, Kellee F Greene, Alyssa R Aldrich, et al.
Annals of Internal Medicine|July 21, 2010
Contextual errors and failures in individualizing patient care: a multicenter studySaul J Weiner, Alan Schwartz, Frances Weaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2015
Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancersJulia L Marcus, Chun Chao, Wendy A Leyden, et al.
Research Square|November 24, 2025
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancerPriyanka Rajan, Robert Zollo, Yanqi Guo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 2011
HIV infection, immunodeficiency, viral replication, and the risk of cancerMichael J Silverberg, Chun Chao, Wendy A Leyden, et al.
Integrative Cancer Therapies|February 27, 2013
Integrating dietary supplements into cancer careMoshe Frenkel, Donald I Abrams, Elena J Ladas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancerPriyanka Rajan, Robert Zollo, Yanqi Guo, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2026
Iron diminishes immunosuppressive macrophages and enhances anti-PD-1 immunotherapy in breast cancer modelsQingfei Wang, Elizabeth L Adams, Rylee A Poole, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancersFengzhi Li, Xiang Ling, Sayan Chakraborty, et al.
Pageof 38